Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival

Krithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, Oscar Calzada, Michael C. Churnetski, Bhaskar C Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, Narendranath EpperlaDavid A. Bond, Talha Badar, Kristie A. Blum, Mehdi Hamadani, Timothy S. Fenske, Mary Malecek, Brad S. Kahl, Peter Martin, Jin Guo, Christopher R. Flowers, Jonathon B. Cohen

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival'. Together they form a unique fingerprint.

Medicine & Life Sciences